Picture of Essex Bio-Technology logo

1061 — Essex Bio-Technology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Brief: Essex Bio-Technology Says Unit Obtained Approval From State Drug Administration For A Product

Aug 22 (Reuters) - Essex Bio-Technology Ltd  1061.HK :
    * GETS APPROVAL TO COMMERCIALISE PRESERVATIVE-FREE
SINGLE-DOSE
SODIUM HYALURONATE EYE DROPS IN CHINA
    * SAYS UNIT OBTAINED APPROVAL FROM STATE DRUG ADMINISTRATION
FOR
PRODUCT

Source text for Eikon:  ID:nHKSbxnV7y 
Further company coverage:  1061.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Essex Bio-Technology

See all news